LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,481 | -41,912 | -30,079 | -19,605 | -8,955 |
| Depreciation Amortization | 142 | 347 | 209 | 95 | 11 |
| Accounts payable and accrued liabilities | -98 | 2,322 | 1,837 | 1,113 | 1,729 |
| Other Working Capital | -390 | 3,294 | 2,825 | 986 | 33 |
| Other Operating Activity | 3,824 | 10,766 | 8,506 | 6,169 | 1,673 |
| Operating Cash Flow | $-13,003 | $-25,183 | $-16,702 | $-11,242 | $-5,509 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -478 | -1,816 | -1,681 | -1,325 | -391 |
| Investing Cash Flow | $-478 | $-1,816 | $-1,681 | $-1,325 | $-391 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 85 | 104,911 | 104,883 | 57 | 57 |
| Financing Cash Flow | $85 | $104,911 | $104,883 | $57 | $57 |
| Beginning Cash Position | 126,467 | 48,555 | 48,555 | 48,555 | 48,555 |
| End Cash Position | 113,071 | 126,467 | 135,055 | 36,045 | 42,712 |
| Net Cash Flow | $-13,396 | $77,912 | $86,500 | $-12,510 | $-5,843 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,003 | -25,183 | -16,702 | -11,242 | -5,509 |
| Capital Expenditure | -478 | -1,816 | -1,681 | -1,325 | -391 |
| Free Cash Flow | -13,481 | -26,999 | -18,383 | -12,567 | -5,900 |